In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


HAIs (healthcare-associated infections) evolution explains UK C diff (Clostridium difficile) testing focus

This article was originally published in Clinica

Executive Summary

UK efforts to tackle methicillin-resistant Staphylococcus aureus (MRSA) appear to be succeeding in reducing bloodstream healthcare-associated infection (HAI) rates, but a further jump in cases of Clostridium difficile - a non-bloodstream HAI - explains the current drive to further tighten surveillance (see related story).






Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts